Press Releases

Project Aims to Streamline and Shorten Drug Development for Tuberculosis New York, NY and Waltham, MA., February 21, 2006 –

At its October 2005 Board Meeting, the TB Alliance Board of Directors appointed two new Board members to three-year terms:

Bayer Healthcare AG has signed an agreement with the Global Alliance for TB Drug Development to study whether the quinolone

NEW YORK CITY (July 5, 2005) — The TB Alliance announced the appointment of Ms. Nina Schwalbe as Director of

Trial is First in TB Alliance’s Growing Pipeline of Drugs — Provides Model for Future Drug Development NEW YORK CITY

Program Commits to Affordable Pricing New York/London – March 21, 2005 – The Global Alliance for TB Drug Development (TB

New York/Amsterdam – February 3, 2005 – The Department of Development Cooperation of the Netherlands Ministry of Foreign Affairs (DGIS),

The Global Alliance for TB Drug Development (TB Alliance) and Novartis Institute for Tropical Diseases (NITD) announced their plans to

NEW YORK, NY – OCT 20, 2004 – The Global Alliance for TB Drug Development (TB Alliance), a public-private partnership

New Donor Brings Support for Innovative Drug Development to $50 million The United States Agency for International Development (USAID), the